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Biomimetic Calcium-Silicate Cements Support Differentiation Of Human 
Orofacial Mesenchymal Stem Cells 
Abstract 
Introduction 
Human orofacial bone mesenchymal stem cells (OFMSCs) from maxilla and mandible have robust 
osteogenic regenerative properties based on our previous reports that demonstrate phenotypic and 
functional differences between jaw and axial bone mesenchymal stem cells in same individuals. 
Furthermore, a combination of OFMSCs with bioactive calcium-releasing cements can potentially improve 
OFMSC multi-lineage differentiation capacity, but biocompatibility of calcium silicate cements with 
OFMSCs is still unclear. We tested the hypothesis that material extracts of calcium-releasing calcium-
silicate cements support biomimetic microenvironment for survival and differentiation of human 
OFMSCs. 
Methods 
Two experimental calcium-silicate cements 1) calcium-silicate mineral powder (wTC) containing di- and 
tricalcium-silicate, calcium sulphate, and calcium chloride and 2) wTC doped with alpha-tricalcium 
phosphate (wTC-αTCP) were designed and prepared. Cement setting times were assessed by Gilmore 
needles, ability to release calcium and hydroxyl ions was assessed by potentiometric methods and 
OFMSC attachment to calcium-silicate discs was assessed. Calcium-silicate material extracts were 
tested for ability to support OFMSCs survival and in vitro/in vivo differentiation. 
Results 
Fewer OFMSCs attached to calcium-silicate discs relative to tissue culture plastic (p=0.001). Extracts of 
calcium-silicate cements sustained OFMSC survival, maintained steady state levels of vascular cell 
adhesion molecule-1, alkaline phosphatase and bone sialoprotein while upregulating their respective gene 
transcripts. Adipogenic and in vivo bone regenerative capacities of OFMSCs were also unaffected by 
calcium-silicate extracts. 
Conclusions 
Ion-releasing calcium-silicate cements support a biomimetic microenvironment conducive to survival and 
differentiation of OFMSCs. Combination of OFMSCs and calcium-silicate cement can potentially promote 
tissue regeneration in periapical bone defects. 
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Abstract
Introduction—Human orofacial bone mesenchymal stem cells (OFMSCs) from maxilla and
mandible have robust osteogenic regenerative properties based on our previous reports that
demonstrate phenotypic and functional differences between jaw and axial bone mesenchymal stem
cells in same individuals. Furthermore, a combination of OFMSCs with bioactive calcium-
releasing cements can potentially improve OFMSC multi-lineage differentiation capacity, but
biocompatibility of calcium silicate cements with OFMSCs is still unclear. We tested the
hypothesis that material extracts of calcium-releasing calcium-silicate cements support biomimetic
microenvironment for survival and differentiation of human OFMSCs.
Methods—Two experimental calcium-silicate cements 1) calcium-silicate mineral powder
(wTC) containing di- and tricalcium-silicate, calcium sulphate, and calcium chloride and 2) wTC
doped with alpha-tricalcium phosphate (wTC-αTCP) were designed and prepared. Cement setting
times were assessed by Gilmore needles, ability to release calcium and hydroxyl ions was assessed
by potentiometric methods and OFMSC attachment to calcium-silicate discs was assessed.
Calcium-silicate material extracts were tested for ability to support OFMSCs survival and in vitro/
in vivo differentiation.
Results—Fewer OFMSCs attached to calcium-silicate discs relative to tissue culture plastic
(p=0.001). Extracts of calcium-silicate cements sustained OFMSC survival, maintained steady
state levels of vascular cell adhesion molecule-1, alkaline phosphatase and bone sialoprotein while
upregulating their respective gene transcripts. Adipogenic and in vivo bone regenerative capacities
of OFMSCs were also unaffected by calcium-silicate extracts.
Conclusions—Ion-releasing calcium-silicate cements support a biomimetic microenvironment
conducive to survival and differentiation of OFMSCs. Combination of OFMSCs and calcium-
silicate cement can potentially promote tissue regeneration in periapical bone defects.
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Orofacial bone mesenchymal stem cells (OFMSCs) from maxilla and mandible are postnatal
mesenchymal stem cells with inherently higher survival and osteogenic properties than bone
mesenchymal stem cells (BMSCs) from non-oral bones (1, 2). We have previously shown
that in same individuals, BMSCs in the jaw (i.e. OFMSCs) are skeletally site-specific based
on proliferation, survival, differentiation and in vivo regenerative properties (1–3). A
combination of the biology of the local microenvironment and circulating levels of soluble
calcium and inorganic phosphates have been correlated with bone regeneration(4, 5);
therefore calcium-silicate cements also known as Mineral Trioxide Aggregates (MTA)
cements are used clinically in oral surgery and root canal therapy. Calcium-silicate cements
have attractive chemical, physical and biological properties that include ability to set in the
presence of moisture, the release of calcium ions, and ability to form apatite in the presence
of phosphate-containing simulated-body fluids (6–11).
The bioactive properties of calcium-silicate cements combined with bio-interactivity (12)
with local microenvironment may be conducive to cell survival and bone regeneration (13),
but there is paucity of information on effects of calcium-silicate cements on jaw specific
mesenchymal stem cells (14). Alpha-tricalcium phosphate (α-TCP) is a reactive compound
that can serve as a source of phosphate (15) and calcium ions (16) for apatite formation (17)
and tissue regeneration. Although calcium-silicate cements are more resorbable than
hydroxyapatite-tricalcium phosphate commonly used to promote bone regeneration, they
can potentially stimulate appropriate biomimetic microenvironments for OFMSC
differentiation because they have been shown to promote attachment and proliferation of
osteoblast-like cells and dental pulp stem cells (DPSCs) (5, 18). DPSCs share similar
embryological origin with OFMSCs (1, 19) but OFMSCs display higher osteogenic
differentiation (2). A combination of superior osteogenesis of OFMSCs with biomimetic
properties of calcium-silicate cements is attractive for bone regeneration, but
biocompatibility of calcium-silicate material extracts with survival and regenerative
properties of OFMSCs are still unclear.
The aim of this study was to determine the biocompatibility of OFMSCs with biomimetic
properties of two calcium-silicate preparations: 1) calcium-silicate mineral powder (wTC)
containing di- and tricalcium-silicate, calcium sulphate and calcium chloride; and 2) wTC
doped with alpha-tricalcium phosphate (wTC-αTCP). We hypothesized that calcium ions
and other minerals (silicon and phosphorous) in material extracts released by calcium-
silicate cements will provide supportive biomimetic microenvironment for survival and
differentiation of human OFMSCs.
Materials and Methods
Preparation of calcium silicate cements
Experimental calcium-silicate mineral powder (wTC) containing di- and tricalcium-silicate,
calcium sulphate, calcium chloride; and another wTC doped with alpha-tricalcium
phosphate (wTC-αTCP) were designed and produced. The grinded mineral powders were
mixed using 1 g of cement per 0.300 ml of calcium and magnesium free Dulbecco s
Phosphate Buffered Saline (DPBS) pH 7.4 (Lonza Walkersville Inc, Walkersville, MD,
USA, Cat #17–512) on a glass plate with stainless-steel spatula. A homogeneous paste was
achieved within 30 seconds and packed into a circular polyvinyl chloride (PVC) mold (8
mm internal diameter and 1.6 mm thickness) to obtain a smooth surface.
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Setting times of cements
Calcium-silicate cement (wTC and wTC-αTCP) discs covered on upper and lower surfaces
with wet gauze to prevent dehydration were placed in a hermetically sealed curing chamber
(37°C and 98% relative humidity) before evaluating setting times. Gilmore needles were
used to assess setting times according to ASTM C266-03 (American Society for Testing and
Materials International) and ISO 9917-1 (International Organization for Standardization)
(20, 21). Briefly described, Gilmore initial setting time was the elapsed time (in minutes)
between the mixing of the cement with liquid and the first penetration measurement that
does not mark the specimen surface with a complete circular impression. As either the initial
or final setting times approached (i.e. no indentation), the specimens were tested every
minute to determine the exact Gilmore setting time. Following initial setting time, the
specimens were assessed every 5 minutes until final stetting time was determined. Weight/
diameter of Gilmore needle used were 113.4 g/2.12 mm and 453.6-g/1.06 mm to test initial
and final setting times respectively (20). Setting time testing was performed on three
replicates for each material and each sample was used for only one indentation test.
Calcium release and alkalinizing activity of cements
Calcium-silicate cement (wTC and wTC-αTCP) discs (n=10 for each material) were
immediately immersed in 10 ml of deionized water (pH 6.8) in polypropylene sealed
containers at 37°C. Soaking water was collected at 3 and 24 hours and after 7, 14 and 28
days to assess pH and calcium content. Calcium released in soaking water was measured
using a calcium probe (Calcium ion electrode, Eutech instruments Pte Ldt, Singapore) after
addition of 0.200 ml (2%) of ionic strength adjuster (ISA, 4 mol/L KCl, WTW, Weilheim,
Germany). The pH of soaking water was measured using a selective temperature
compensated electrode (Sen Tix Sur WTW, Weilheim, Germany) and a previously
calibrated multi-parameter laboratory meter (inoLab 750, WTW Weilheim, Germany). The
probes were inserted into the soaking media at room temperature (24°C) with continuous
stirring. Each measurement was repeated three times.
Calcium-silicate disc and extract preparations for cell culture
Calcium-silicate cement (wTC and wTC-αTCP) discs for OFMSC culture were prepared as
above using a circular PVC mold (12 mm internal diameter and 1.6 mm thickness). To
obtain partial setting, cements were kept for 1 hour at 37°C and 95% relative humidity to
allow for hydration and setting reactions. Cements discs were de-molded and sterilized for 2
hours in antibiotic medium consisting of α-modified minimum essential medium (α-MEM),
100 U/ml penicillin, 100 mg/ml streptomycin sulfate and 25 μg/ml amphotericin B. Discs
were washed free of antibiotic medium with sterile PBS before using for cell attachment
assay. Cement discs prepared in the similar manner as above were allowed to set for 1 hour
at room temperature instead of 37°C, transferred to a 24-well culture plate and sterilized
with antibiotic medium as above. Discs were incubated in 1.5 ml fresh α-MEM containing
100 U/ml penicillin, 100 mg/ml streptomycin sulfate and 2 mM glutamine at 37°C in
humidified atmosphere for 24 hours to allow for release of calcium and silicate ions into the
medium. The supernatant collected was referred to as material extract. wTC and wTC-αTCP
material extracts were passed through separate 0.22 μm filters, pH recorded with
colorimetric strips, and kept at 4°C until used for cell culture.
Culture of orofacial bone mesenchymal stem cells
Human OFMSCs were expanded from primary cultures of human maxilla and mandible
primary bone mesenchymal stem cells previously isolated under an existing protocol
approved by the University of Pennsylvania Institutional Review Board. The cells were
cultured in growth medium consisting of α-MEM supplemented with 10% fetal bovine
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serum (FBS) (Equitech Bio Inc., Kerville TX), 100 U/ml penicillin, 100 mg/ml streptomycin
sulfate and 2 mM glutamine (BioSource International Camarillo CA), incubated at 37ºC in a
humidified atmosphere of 5% CO2 and air as previously described (1). Passage 3 OFMSCs
were used for all experiments.
Attachment of OFMSCs to calcium-silicate discs
Sterile 12 mm diameter wTC and wTC-αTCP discs prepared as above were transferred into
separate wells of a 24-well culture plate containing α-MEM growth medium. 2.0 × 104
OFMSCs were seeded on triplicate wTC and wTC-αTCP discs and in blank wells so that
tissue culture plastic served as control. After 24 hours, the discs were transferred to another
24-well plate. Attached cells were released with trypsin/EDTA and cell scraper before
counting with a hemocytometer.
OFMSC survival in calcium-silicate extracts
OFMSCs were seeded in 96-well plate at 3.2 × 104 cells per well. After 24 hours, α-MEM
growth medium was changed so that three sets of 11 wells received extract of wTC or wTC-
αTCP or fresh α-MEM growth medium. After another 72 hours in culture, surviving cells
were assessed using colorimetric WST-1 cell proliferation assay (Roche Applied Science,
Indianapolis, IN, USA) according to manufacturer s instructions.
Lineage differentiation of OFMSCs in calcium-silicate extracts
Osteogenesis—OFMSCs seeded at 9.5 × 104 cells per well in duplicate wells of a 6-well
plate were kept in culture for 24 hours before exposure to either wTC or wTC- αTCP
material extract prepared as above. Control cells received fresh α-MEM growth medium.
After 48 hours, the cells were replenished with osteogenic medium consisting of α-MEM,
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin sulfate, 2 mM glutamine, 10−8 M
dexamethasone and 100 μM L-ascorbic acid phosphate magnesium-hydrate. After another
48 hours, total protein was collected using Mammalian Protein Extraction Reagent (M-PER,
Pierce Biotechnology, Rockford, IL). In a similar set up of parallel experiment, total RNA
was isolated with Trizol reagent (Invitrogen, Carlsbad, CA).
Western blotting—Protein amount was determined with BCA protein assay (Pierce
Biotechnology, Rockford, IL). 50 μg protein was separated in 4–12% Bis–Tris gel
(Invitrogen, Carlsbad, CA) under reducing conditions and western blotting was performed as
previously described (3). Membranes were probed with the following primary antibodies:
1:200 dilution of mouse monoclonal anti-vascular cell adhesion marker-1 (VCAM-1,
ab19264, AbCam, Cambridge MA), 1:100 dilution of mouse monoclonal anti-bone
sialoprotein (BSP, LFMb-25, kindly provided by Dr. Larry Fisher, National Institute of
Dental and Craniofacial Research/National Institutes of Health [NIDCR/NIH], Bethesda
MD) and 1:200 rabbit anti-alkaline phosphatase (ALP, LF47, gift from Dr. Larry Fisher,
NIDCR/NIH). Mouse anti-α-tubulin (12G10, Developmental Studies Hybridoma Bank,
Iowa City, IA) at 1:200 dilution served as protein loading control. After probing with
1:5000–1:10000 dilution of specie-specific secondary antibody conjugated to horseradish
peroxidase, the immunoreactive bands were detected with chemiluminescent reagents (GE
Healthcare, UK) and analyzed digitally with Kodak Image Station 4000MM (Molecular
Imaging Systems, Carestream Health, Rochester, NY). Relative abundance of adhesion and
osteogenic markers were normalized to α-tubulin.
Real time-PCR—cDNA was prepared from 2 mg of total RNA using oligo(dT) and
SuperScript First-Strand Synthesis System for reverse transcriptase PCR (Invitrogen,
Carlsbad, CA). Real-time PCR reaction was performed in ABI 7300 Real-Time PCR System
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using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and
primer sets designed with Primer Express software (Applied Biosystems, Foster City, CA)
and GenBank sequences for: human VCAM-1 - forward, 5′-
GAAGGAATTAACCAGGCTGGAA-3′, reverse, 5′-
AGTTTTATGTCTTTTGGAGTAACTTG-3′; human ALP - forward, 5′-
CCGTGGCAACTCTATCTTTGG-3′, reverse, 5′-GATGGCAGTGAAGGGCTTCTT-3′;
human BSP - forward, 5′-AACGAAGAAAGCGAAGCAGAA-3′, reverse, 5′-
TCTGCCTCTGTGCTGTTGGT-3′ and human TATA binding protein (TBP) - forward, 5′-
GGAGCTGTGATGTGAAGTTTCCTA-3′, reverse, 5′-
CCAGGAAATAACTCTGGCTCATAAC-3′ used as endogenous control. A negative PCR
control without template was included in each assay. Gene expression levels normalized to
TBP and presented as relative fold change using the ΔΔCt method (Applied Biosystems,
Foster City, CA) was used to quantify changes in mRNA levels in response to material
extracts.
Adipogenesis—2 × 104 OFMSCs plated in duplicate 60 mm dishes were treated with
material extracts as above. They were further cultured for 4 weeks in adipogenic medium
consisting of α-MEM supplemented with 10−8 M dexamethasone, insulin (1 μg/ml), 1-
methyl-3-isobutylxanthine (IBMX, 5 × 10−8 M) and indomethacin (10−4 M); medium was
changed twice weekly. The cells were fixed with 4% paraformaldehyde, stained with 0.3%
Oil Red O and counterstained with 1% Fast green dye. Lipid droplets were assessed
microscopically.
In vivo bone regeneration by OFMSCs exposed to calcium-silicate extracts
Using both extract-exposed and control OFMSCs, 2 × 106 cells attached to 40 mg of
spheroidal hydroxyapatite tricalcium phosphate (particle size 0.5–1.0 mm; Zimmer,
Warsaw, IN, USA) were transplanted aseptically into separate subcutaneous pockets of 8-
week-old immunocompromised female nude mice (NIH-III-nu; Charles River Laboratories,
Wilmington, MA, USA) as previously described (1, 3) and in accordance with animal
protocol approved by University of Pennsylvania Institutional Animal Care and Use
Committee. Transplants were harvested at 6 weeks, fixed with 4% paraformaldehyde,
decalcified in 10% ethylenediaminetetraacetic acid (EDTA) (pH 8.0) and embedded in
paraffin. Hematoxylin eosin-stained 5 μm sections were evaluated and quantified
microscopically as previously described (1, 3).
Statistical analysis
Results were expressed as mean ± standard deviation (SD). Differences between groups
were analysed with one-way analysis of variance (ANOVA) followed by post hoc
comparisons with Tukey-Kramer test using SigmaStat 3.1, Systat Software, Inc., Chicago,
IL). Statistical significance was set at P < 0.05.
Results
Setting reaction initiated earlier and hardness was completed faster in wTC-αTCP discs
relative to wTC (Table 1). Similarly, release of calcium ions in unset freshly prepared
cement was also faster in wTC-αTCP within the first 3 hours, but wTC displayed a more
gradual calcium release within the first 24 hours in spite of relatively similar pH of soaking
solution (Table 2). Discs formed from partially and fully set wTC and wTC-αTCP cements
maintained their rigidity and shape irrespective of setting parameters (Figure 1A).
Attachment of OFMSCs to cement discs was much lower than tissue culture plastic (p
=0.001) but wTC discs apparently supported slightly more cell attachment than wTC-αTCP
(Figure 1B). Exposure of sub-confluent monolayer of OFMSCs to cement extracts reduced
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cell-to-cell contact and plastic adherence (Figures 1C–E). There were evidences of cement
sediments and free floating cells in the wTC and wTC-αTCP culture environments while
control cells in α-MEM continued proliferation to 100% cell confluence (Figures 1C–E).
Despite the sub-optimal culture conditions in material extracts, OFMSCs exposed to cement
extracts displayed 80–98% survival relative to control cells in α-MEM but there was no
statistically significant difference between wTC and wTC-αTCP extracts (p = 0.07) (Figure
1F). OFMSC levels of VCAM-1, a marker of cell attachment was unaffected by cement
extracts based on western blot analysis (Figures 2A and B), but mRNA expression was
upregulated as shown by real time PCR (Figure 2C). Similarly, protein levels of ALP and
BSP remained at baseline level in OFMSCs exposed to cement extracts (Figure 2B) but
mRNA levels of ALP and not BSP were distinctly upregulated by extracts of both wTC and
wTC-αTCP (Figure 2C). There was no significant difference between wTC and wTC-αTCP.
Interestingly, aggregates of fat droplets were fewer numerically but structurally larger in
OFMCs pre-treated with material extracts relative to control cells (Figures 3A–C). Similarly
OFMSCs pre-treated with material extracts before transplantation into immunocompromised
mice regenerated appreciable in vivo bone structurally (Figures 3D–F) and quantitatively
(Figure 3G) similar to those of control cells.
Discussion
Large periapical bone defects pose a surgical challenge in endodontic practice. They often
require the use of bioactive materials like calcium silicate to promote apical bone healing
(22–24). Calcium-silicate cements release calcium ions and the presence of Si-OH groups
triggers the formation of a layer of apatite on the cement surface (6). Both wTC and wTC-
αTCP calcium-silicate cements tested in this study set rapidly and released appreciably high
calcium ions within the first 24 hours of fluid exposure. The ion-releasing effect that
gradually tapered down within 7 days can therefore counteract potential tissue accumulation
and cytotoxicity. Calcium and silicon ions released from bioactive glasses have been shown
to stimulate osteoblast proliferation and gene expression (25–27). It is possible that calcium
ion-releasing ability of cements tested in this study also favor OFMSC differentiation and
jaw bone healing (28). We found that OFMSCs attachment to cements was low relative to
tissue culture plastic, but they maintained proliferation and survival in the calcium-rich
extract generated by the cements. While both types of calcium-silicate cement set rapidly
and maintained their rigidity to allow for cell attachment, the reduced OFMSC attachment
observed is similar to previously described attachment to oxidized titanium commonly used
to promote osseointegration of dental implants (19). The relatively non-suppressible protein
levels of VCAM-1, ALP and BSP and upregulation of their respective transcripts support
ability of OFMSCs to differentiate in a calcium rich extract. Ability to induce adipogenesis
and in vivo bone formation despite pre-treatment with cement extracts also support previous
reports that osteoprogenitor cells respond to critical concentrations of calcium and silicate
released by fresh cement surfaces (14, 28) and sol-gel bioactive glasses (29). In spite of
reduced OFMSC attachment and survival, the residual OFMSCs demonstrated enhanced
adipogenesis and comparatively similar in vivo bone formation as control cells. Therefore,
gradual release of calcium and silicate ions from calcium-silicate cements may represent
another stimulatory signal for OFMSC differentiation. Apart from larger aggregates of lipid
droplets, there were no significant differences between wTC and wTC-αTCP on OFMSCs
differentiation. Previous reports have demonstrated that different α-TCP doped calcium-
silicate cements have enhanced bioactivity i.e. faster/higher apatite-forming ability (30, 31)
but they also slightly reduced the proliferation of human BMSCs seeded on their surface
(13).
Calcium-silicate cements have been proposed as root-end filling materials and root-canal
sealers in endodontic therapy (23). Specifically, wTC and wTC-αTCP formulations can be
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used in contact with bone to seal defects and apices of resected teeth after apicoectomy;
hence they can promote periapical bone regeneration and healing. Our study indicates the
compatibility of wTC and wTC-αTCP calcium-silicate cements with OFMSCs, so if
cements leach into surrounding bone, survival of resident osteoprogenitor cells will be
relatively unaffected. Although calcium-silicate is more resorbable and less osteoconductive
than hydroxyapatite-tricalcium phosphate commonly used to stimulate MSCs to form bone
(1, 19), the present study shows that calcium-silicate cements have the potential to stimulate
appropriate biomimetic microenvironments for OFMSC differentiation. Clinically, this
property can ultimately promote rapid bone healing of large periapical bone defects
following endodontic surgery. Additionally, we have previously reported that OFMSCs
support hard tissue regeneration whether induced or non-induced (1); therefore, superior
osteoregenerative and survival properties of OFMSCs in the milieu of ion-releasing calcium-
silicates make OFMSCs attractive graft materials in endodontic surgery. Further studies are
still warranted on the clinical applications of OFMSC-calcium silicate composite as donor
grafts in endodontic surgery.
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Effect of calcium silicate cements on attachment and survival of OFMSCs. Representative
images of calcium silicate cements within the PVC mold (A, top panel) and after recovery
from the mold (A, lower panel) indicate rigidity of the calcium silicate discs was maintained
irrespective of setting parameters. OFMSC attachment to silicate discs was significantly
lower (p = 0.001) than cells attached to tissue culture plastic (B). Plastic adherence in α-
MEM culture medium (C) was reduced when OFMSCs were introduced to cement extracts
(D, E) as demonstrated by floating cells and partial loss of cell-to-cell contact. Metabolically
active cells in calcium silicate extracts and α-MEM were similar based on WST-1 survival
assay (F) and there were no significant differences between surviving cells in wTC and
wTC-αTCP extracts (p = 0.074). [*** = p ≤ 0.001].
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Effects of calcium silicate cements on in vitro differentiation of OFMSCs.
Representative Western blot bands of control (α-MEM), wTC and wTC-αTCP extract-
treated OFMSCs proteins showed immunoreativity to vascular cell adhesion marker-1
(VCAM-1), alkaline phosphatase (ALP), bone sialoprotein (BSP) and α-tubulin [protein
loading control] (A). Densitometric analysis of immunoreactive bands (B) showed minimal
changes in VCAM-1 and BSP levels relative to control cells but ALP level was slightly
more reduced in OFMCS exposed to wTC-αTCP extracts. Real time PCR amplification of
specific primers for the same markers demonstrated significant upregulation of their gene
transcripts with ALP > VCAM-1 > BSP (C) [PCR data normalized to non-osteogenic
controls and TATA binding protein as housekeeping gene]. There were no significant
differences between the two cement types.
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Effect of calcium silicate cements on adipogenesis and in vivo bone regeneration. Lipid
aggregates (black arrow heads) were randomly distributed around majority of α-MEM-
cultured (control) OFMSCs (A), while wTC and wTC-αTCP extract-treated cells displayed
fewer but structurally larger lipid aggregates (B, C) than control cells. Similarly OFMSCs
pre-treated with material extracts regenerated appreciable in vivo bone (black solid arrows)
structurally similar to those of control cells (D, E, F); and there were no differences in
amount of bone regenerated by extract-treated and α-MEM-treated OFMSCs (G) [* =
hydroxyapatite carrier; clear arrow = fibrous tissues].
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Table 1
Duration of setting reactions of calcium-silicate cements
Initiation and completion of cement setting reaction
Setting reaction (minutes)
Initiation Completion
wTC 72.0 ± 4.1 135.5 ± 7.9
wTC-TCP 47.6 ± 5.6 79.3 ± 7.9
n =10 samples tested per cement type
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Table 2
Quantity of calcium ions released by calcium-silicate cements and pH of soaking water
Release of calicum and pH of soaking solution
Calcium release (ppm)*
3 hours 1 day 3 days 7 days
wTC 250 2 ± 12.1 129 2 ± 14 1 120.6 ± 3.5 19.8 ± 3.0
wTC-TCP 368.9 ± 9.6 88.8 ± 4.2 14.2 ± 4.7 16.2 ± 2.9
pH soaking solution
wTC 12.0 ± 0.1 11.3 ± 0.4 10.2 ± 0.3 9.6 ± 0.3
wTC-TCP 11.6 ± 9.6 11.2 ± 0.4 9.6 ± 0.4 9.1 ± 03
n =10 samples tested per cement type
*
ppm = parts per million
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